European equities traded in the US as American depositary receipts kicked off the week moderately higher late Monday morning, rising 0.84% to 1,395.97 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and internet browser company Opera (OPRA), which rose 6.9% and 4.3%, respectively. They were followed by biotech firm BioNTech (BNTX) and biopharmaceutical company Genfit (GNFT), which were up 4.2% and 3.9%, respectively.
The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS), which lost 4.6%, and furniture maker Natuzzi (NTZ), which retreated 3.6%. They were followed by internet advertising firm Criteo (CRTO) and telecommunications firm Nokia (NOK), which were down 3% and 0.8%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma (VRNA) and cruise line operator Carnival (CUK), which increased 4.3% and 2.7%, respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and NuCana (NCNA), which advanced 2.4% and 2.3%, respectively.
The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Amarin (AMRN), which fell 3.8% and 1.3% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Akari Therapeutics (AKTX), which were off 0.4% and 0.3% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。